Event Journées Européennes du Patrimoine 2019 September 21st 2019de 2:00 pm à 5:00 pm Job offer Offre de stage – Technicien en recherche médicale (H/F) 20 September 2019 Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Call for proposals Call for proposal DIM Gene Therapy 2019 26 July 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Event CRISPR/Cas9 seminar at Imagine Institute July 1st 2019de 1:00 pm à 2:00 pm Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Job offer Assistant Engineer position CDD 12 month 17 May 2019 Call for proposals Exceptionnal extension – Call for Proposal DIM 2019 7 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Job offer Offre de stage – Technicien en recherche médicale (H/F) 20 September 2019 Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Call for proposals Call for proposal DIM Gene Therapy 2019 26 July 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Event CRISPR/Cas9 seminar at Imagine Institute July 1st 2019de 1:00 pm à 2:00 pm Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Job offer Assistant Engineer position CDD 12 month 17 May 2019 Call for proposals Exceptionnal extension – Call for Proposal DIM 2019 7 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Call for proposals Call for proposal DIM Gene Therapy 2019 26 July 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Event CRISPR/Cas9 seminar at Imagine Institute July 1st 2019de 1:00 pm à 2:00 pm Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Job offer Assistant Engineer position CDD 12 month 17 May 2019 Call for proposals Exceptionnal extension – Call for Proposal DIM 2019 7 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Call for proposals Call for proposal DIM Gene Therapy 2019 26 July 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Event CRISPR/Cas9 seminar at Imagine Institute July 1st 2019de 1:00 pm à 2:00 pm Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Job offer Assistant Engineer position CDD 12 month 17 May 2019 Call for proposals Exceptionnal extension – Call for Proposal DIM 2019 7 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Event CRISPR/Cas9 seminar at Imagine Institute July 1st 2019de 1:00 pm à 2:00 pm Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Job offer Assistant Engineer position CDD 12 month 17 May 2019 Call for proposals Exceptionnal extension – Call for Proposal DIM 2019 7 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Event CRISPR/Cas9 seminar at Imagine Institute July 1st 2019de 1:00 pm à 2:00 pm Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Job offer Assistant Engineer position CDD 12 month 17 May 2019 Call for proposals Exceptionnal extension – Call for Proposal DIM 2019 7 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Job offer Assistant Engineer position CDD 12 month 17 May 2019 Call for proposals Exceptionnal extension – Call for Proposal DIM 2019 7 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Job offer Assistant Engineer position CDD 12 month 17 May 2019 Call for proposals Exceptionnal extension – Call for Proposal DIM 2019 7 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Job offer Assistant Engineer position CDD 12 month 17 May 2019 Call for proposals Exceptionnal extension – Call for Proposal DIM 2019 7 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Call for proposals Exceptionnal extension – Call for Proposal DIM 2019 7 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
Anounce, News New approval in gene therapy for the treatment of beta-thalassemia 23 April 2019 Page 4 sur 5«12345»
